Using transcriptomic profiles from multiple datasets, researchers developed a machine learning–based Breast Cancer Classifier (BCC) that identified a distinct HER2-low molecular subtype not captured by conventional PAM50 or immunohistochemistry assays [166]. This evidence concerns the gene ERBB2 and breast cancer.